Clover Health Investments (CLOV) vs Progyny (PGNY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Clover Health Investments (CLOV) has outperformed Progyny (PGNY) over the past year, gaining 68.9% versus a gain of 37.8%. Over five years, CLOV leads with a -42.4% price change compared with -50.8% for PGNY. Clover Health Investments is the larger company by market cap ($2.42 billion vs $2.11 billion), about 1.1 times the size.
On valuation, Progyny trades at a lower forward P/E (11.9x vs 30.4x for Clover Health Investments).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLOV | PGNY |
|---|---|---|
| Share price | $4.56 | $27.55 |
| Market cap | $2.42B | $2.11B |
| 1-day change | -0.87% | +6.33% |
| YTD return | +94.04% | +7.28% |
| 1-year return | +68.89% | +37.75% |
| 5-year return | -42.35% | -50.79% |
| P/E ratio (TTM) | — | 29.95 |
| Forward P/E | 30.40 | 11.88 |
| EPS (TTM) | $-0.05 | $0.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.59 | $33.07 |
| 52-week low | $1.58 | $16.10 |
| Distance from 52-week high | -18.43% | -16.68% |
| Analyst consensus | none | none |
| Avg. price target upside | +17.98% | +24.94% |
| Average volume | 4.27M | 1.13M |
| Shares outstanding | 435.44M | 76.73M |
| Employees | 724 | 835 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CLOV has outperformed PGNY by 31.1 percentage points over the past year.
About Clover Health Investments
CLOV stock →Clover Health Investments, Corp. provides medicare advantage plans in the United States.
Health Care · Medical Specialities · 724 employees
About Progyny
PGNY stock →Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Health Care · Misc Health and Biotechnology Services · 835 employees
CLOV vs PGNY FAQ
Which is bigger, Clover Health Investments or Progyny?
Clover Health Investments (CLOV) is larger, with a market capitalization of $2.42B compared with $2.11B for Progyny (PGNY).
Which stock has performed better over the past year, CLOV or PGNY?
CLOV returned +68.89% over the past 12 months, compared with +37.75% for PGNY (price return, excluding dividends). Past performance does not predict future results.
Are Clover Health Investments and Progyny in the same industry?
Both are in the Health Care sector, but in different industries: Medical Specialities for Clover Health Investments and Misc Health and Biotechnology Services for Progyny.